Helinorm Capsules offer a science-backed, non-antibiotic approach to managing Helicobacter pylori, a common stomach bacterium associated with gastritis, bloating, and digestive discomfort.
Powered by Limosilactobacillus reuteri DSM 17648, this unique probiotic strain works differently from conventional treatments. Instead of killing bacteria, it co-aggregates (binds) with H. pylori cells in the stomach. This binding action reduces bacterial load and supports natural clearance through the digestive system.
Helinorm can be used alongside standard H. pylori eradication therapies (such as triple therapy) or as a supportive option for individuals seeking a gentler, microbiome-friendly approach. Clinical studies using the 13C-urea breath test (UBT) have shown its potential in lowering H. pylori levels.
At Arka, we recommend Helinorm as part of an integrative gut health protocol that combines modern medicine with targeted nutritional and probiotic support.
Limosilactobacillus reuteri DSM 17648 — 200 mg
(Equivalent to not less than 2 billion Lactobacillus reuteri cells)
Duration: Typically 14–28 days or as advised by your healthcare provider